![Tao Tao Ying](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Tao Tao Ying
Directeur/Bestuurslid bij SHANGHAI MODEL ORGANISMS CENTER, INC.
Profiel
Tao Tao Ying is currently the Director at Shanghai Model Organisms Center, Inc. and a Member-Supervisory Board at Shanghai Innostar Biotechnology Co., Ltd.
Mr. Ying has a graduate degree from Shanghai Jiao Tong University and an undergraduate degree from Jiangnan University.
Actieve functies van Tao Tao Ying
Bedrijven | Functie | Begin |
---|---|---|
SHANGHAI MODEL ORGANISMS CENTER, INC. | Directeur/Bestuurslid | 20-05-2022 |
Shanghai Innostar Biotechnology Co., Ltd.
![]() Shanghai Innostar Biotechnology Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Innostar Biotechnology Co., Ltd. engages in the provision of comprehensive research and development services for biopharmaceutical non-clinical research. Its services include early-stage drug discovery, clinical testing & translational research, non-clinical safety evaluation, non-clinical pharmacokinetic studies, and non-clinical pharmacodynamic studies. The company was founded on May 12, 2010 and is headquartered in Shanghai, China. | Directeur/Bestuurslid | 13-08-2021 |
Opleiding van Tao Tao Ying
Jiangnan University | Undergraduate Degree |
Shanghai Jiao Tong University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
SHANGHAI MODEL ORGANISMS CENTER, INC. | Commercial Services |
Bedrijven in privébezit | 1 |
---|---|
Shanghai Innostar Biotechnology Co., Ltd.
![]() Shanghai Innostar Biotechnology Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Innostar Biotechnology Co., Ltd. engages in the provision of comprehensive research and development services for biopharmaceutical non-clinical research. Its services include early-stage drug discovery, clinical testing & translational research, non-clinical safety evaluation, non-clinical pharmacokinetic studies, and non-clinical pharmacodynamic studies. The company was founded on May 12, 2010 and is headquartered in Shanghai, China. | Commercial Services |